Cancer Biology
A discipline of Ph.D. in Integrated Biomedical Sciences
The Cancer Biology discipline is a vibrant community of successful researchers and educators with expertise across the spectrum of bench research to bedside application. The Cancer Biology discipline provides students and fellows rigorous training in fundamentals of cancer biology and translational aspects of cancer research including drug development, prevention and treatment. Our National Cancer Institute (NCI) designed cancer center provides students the opportunity to closely interact with physician scientists. We have Cancer Prevention and Research Institute of Texas and NCI T32 training grants. In addition, our students successfully compete in NCI pre-doctoral fellowships; publish in high impact journals and pursue successful careers at top-tier academic institutes and industries.
Program at a glance
Cancer Biology is a discipline of the Ph.D. in Integrated Biomedical Sciences program.
Requirements
- Bachelor's degree or a Master's degree and relevant advance coursework
- GPA no lower than 3.0
- Submit transcripts to Office of the Registrar
Application Deadlines
- Priority January 1
- Final February 1
Stipend
Students receive a stipend of $30,000. Tuition, fees, and basic student health insurance are covered by the program.
Characteristics
Graduation, student, faculty and institutional statistics for the Integrated Biomedical Sciences Graduate Program.
For information on the Cancer Biology Discipline, please contact:
Manjeet Rao, Ph.D.
Cancer Biology Discipline Director
Phone: 210-562-9191
raom@uthscsa.edu
Judith Quiroz
Cancer Biology Discipline Coordinator
Phone: 210-567-3802
quirozj1@uthscsa.edu
For information on the IBMS Ph.D Program, please contact:
Michael Berton, Ph.D
IBMS Program Director
berton@uthscsa.edu
Donna Navarro, MS
IBMS Assistant Director
navarrod3@uthscsa.edu
"I chose the Cancer Biology discipline because of the interdisciplinary and collaborative environment which fosters innovative translational approaches to improve cancer patient outcomes and survivorship."Kristin Altwegg, 2nd year student